Science & technology
Panasonic at Chillventa 2026: Nanoe™ X Suppresses Proteins of 12 European Pollen Species; Clinical Effect Not Confirmed
Panasonic presented laboratory data at Chillventa 2026 showing that Nanoe™ X reduces the activity of allergenic proteins from 12 European pollen species within 24 hours. The company emphasises that the results do not prove clinical benefit for allergy sufferers.
At Chillventa 2026, Panasonic presented laboratory data in which the Nanoe™ X technology demonstrates suppression of specific allergenic proteins from 12 European pollen species. The company explicitly states that the results do not confirm either a reduction in allergic symptoms or clinical benefit for allergy sufferers.
The tests were conducted under controlled laboratory conditions. After 24 hours of Nanoe™ X exposure to the samples, weakening of bands for a number of allergenic proteins was recorded, which is interpreted as a reduction in their activity. The technology is used in Panasonic's climate control equipment.
The company stated that further research is aimed at strengthening the evidence base for the technology.
ORIGINAL SOURCE
kaeltejobs: Nachrichten ↗Visit the original source for additional details.
